GLREHIGH SIGNALFINANCIAL10-K

GLRE achieved substantial deleveraging by reducing total debt 92% while significantly strengthening its cash position and profitability.

The dramatic debt reduction from $60.7M to $4.7M, combined with a 73% increase in cash to $111.8M, represents a major balance sheet transformation that substantially improves financial flexibility. The company's reinsurance business momentum is evident with 10.7% growth in gross premiums written, while operating cash flow generation more than doubled, demonstrating strong underlying business performance.

Comparing 2026-03-09 vs 2025-03-10View on EDGAR →
FINANCIAL ANALYSIS

GLRE delivered exceptionally strong financial results with net income growing substantially while achieving near-complete debt elimination and a significant cash build to $111.8M. Operating cash flow generation more than doubled to $210.2M, demonstrating robust business performance that supported both the debt paydown and increased shareholder returns through higher buybacks. The combination of deleveraging, improved profitability, and strong cash generation signals a company in excellent financial health with enhanced strategic flexibility.

FINANCIAL STATEMENT CHANGES
Total Debt
Balance Sheet
-92.2%
$60.7M$4.7M

Debt reduced 92.2% — deleveraging strengthens balance sheet and reduces financial risk.

Operating Cash Flow
Cash Flow
+88.5%
$111.5M$210.2M

Operating cash flow surged 88.5% — exceptional cash generation, highest quality earnings signal.

Net Income
P&L
+74.8%
$42.8M$74.8M

Net income grew 74.8% — bottom-line growth signals improving overall business health.

Cash & Equivalents
Balance Sheet
+72.8%
$64.7M$111.8M

Cash position surged 72.8% — strong cash generation or capital raise providing significant financial cushion.

Share Buybacks
Cash Flow
+31.2%
$7.5M$9.8M

Share repurchases increased 31.2% — management returning capital, signals confidence in intrinsic value.

Stockholders Equity
Balance Sheet
+11.3%
$635.9M$708.0M

Equity base grew 11.3% — retained earnings accumulation or equity issuance strengthening the balance sheet.

LANGUAGE CHANGES
NEW — 2026-03-09
PRIOR — 2025-03-10
ADDED
At March 9, 2026, there were 33,983,603 ordinary shares outstanding, $0.10 par value per share, of the registrant.
Summary of Risk Factors The following is a summary of the principal risks that we believe could adversely affect our business, operations, and financial results.
Investments in privately held early-stage companies ( private equities ) involve significant risks, and are highly illiquid.
Refer to Part II, Item 7, Management Discussion and Analysis - Key Financial Measures and Non-GAAP Measures for further details.
Further, since 2018, our Innovations business unit has supported innovative, technology-driven insurance partners, both in the form of seed capital and reinsurance capacity.
Following the business growth momentum in 2024 and 2023, we grew our reinsurance business by 10.7% in gross premiums written during 2025 while maintaining a strong financial position and liquidity.
Supported by strong net cash flows from operating activities, we made further stock buybacks and repaid most of our outstanding debt in 2025.
In light of our strong balance sheet and steadily improved operating performance, A.M.
At December 31, 2025, we had $2.2 billion of total assets and $0.7 billion of shareholders equity, and grew our fully diluted book value per share by 13.8% during 2025.
In connection with certain proposals that passed at our 2023 AGM relating to the elimination of our former dual-class share structure, our Board consented to David Einhorn beneficially owning more than 9.9% of the total voting power of the total issued and outstanding ordinary shares, up to the amount of ordinary shares beneficially owned by Mr.
REMOVED
At March 10, 2025, there were 34,564,176 ordinary shares outstanding, $0.10 par value per share, of the registrant.
We believe that these factors include, but are not limited to: any suspension or revocation of any of our licenses; losses from catastrophes and other major events; a downgrade or withdrawal of our A.M.
Investments in privately held early-stage companies involve significant risks, and are highly illiquid.
Refer to Part II, Item 7, Management Discussion and Analysis - Key Financial Measures and N on-GAAP Measures for further details.
Further, since 2018, we have operated an Innovations business unit to support innovative, technology-driven insurance partners, both in the form of seed capital and reinsurance capacity.
Effective January 1, 2024, we hired a new Chief Executive Officer ( CEO ) who undertook a deep review of our business strategies, in addition to meeting key brokers, major clients and Innovations partners.
While this has not resulted in any material change to the Company s strategic direction; this has led to making some changes to the leadership team with the appointment of a Group Chief Underwriting Officer ( Group CUO ) and Group Chief Operating Officer ( Group COO ) during 2024 in order to more effectively manage the Company s operations and anticipated business growth.
Building from our strong performance in 2023, we grew our reinsurance business by 9.7% in gross premiums written during 2024 while maintaining a strong financial position and liquidity.
At December 31, 2024, we had $2.0 billion of total assets and $0.6 billion of shareholders equity, with a debt-to-capital ratio of 9.5%.
In connection with certain proposals that passed at our 2023 AGM relating to the elimination of our former dual-class share structure, our Board consented pursuant to Section 11(1)(c) of the Articles to David Einhorn beneficially owning more than 9.9% of the total voting power of the total issued and outstanding ordinary shares, up to the amount of ordinary shares beneficially owned by David Einhorn at the time of the consent (i.e., 6,254,715 ordinary shares, which represents 18.0% of the outstanding ordinary shares as of December 31, 2024 ).
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →